Healthcare Stocks Rally on December 22 Amid H3N2 Flu Surge
As the H3N2 flu cases rise sharply in Canada, healthcare stocks have taken a significant leap. On December 22, the market saw a robust surge driven by investor anticipation of increased demand for medical services and pharmaceuticals. Hospitalizations related to the flu have doubled, prompting a closer look at public health measures and the economic implications of the flu season 2025.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
